Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Bhagat Phool Singh Government Medical College for Women
Eligibility
Inclusion criteria
Inclusion criteria: Patients of T2DM with a disease duration of >=10 year and on multivitamins Diabetic neuropathy will be defined as: Patients with diabetes, having or not having clinical symptoms and sign who will have abnormal nerve conduction velocity, including both confirmed and subclinical DPN. Microalbuminuria will be defined as: Urinary excretion of 30 to 300 mg of albumin per g of Creatinine. Macroalbuminuria will be defined as: More than 300 mg of albumin per g of Creatinine
Exclusion criteria
Exclusion criteria: i. Patients of kidney transplantation ii. Patients with non diabetic nephropathy kidney disease iii. Cervical vertebral and lumbar intervertebral disc herniation iv. Acute cerebrovascular events v. Acute coronary events vi. Transaminase level more than two fold higher than normal vii. Serum potassium > 5.5 meq/L viii. Malignant tumor ix. Limb trauma x. Thyroid function abnormalities xi. Alcohol abuse xii. Intake of neurotoxic medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| relationship between albuminuria and diabetic pehripheral neuropathy in patients of type 2 diabetes mellitusTimepoint: baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between degree of albuminuria with severity of diabetic pheripheral neuropathyTimepoint: baseline | — |
Countries
India
Contacts
Public ContactDr Madan Gopal
Bhagat Phool Singh Government Medical College for Women, Khanpur Kalan, Sonepat
Outcome results
None listed